未登录

S

Simona Camorani

consiglio nazionale delle ricerche (cnr)

H指数:21

被引数:1,492

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Urine-Stable Aptamer-Conjugated Gold Nanorods for the Early Detection of High-Grade Bladder Cancer Residual Disease

尿稳定适配体偶联的金纳米棒用于高分级膀胱癌残余病灶的早期检测

ADVANCED HEALTHCARE MATERIALS

IF9.6

2025-02-110

OAAI

Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles (vol 14, 626, 2022)

IF5.5

2024-09-300

OAAI

Bispecifc aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies (vol 43, 92, 2024)

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2024-08-230

OAAI

Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2024-03-264

OAAI

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells

Metalloproteinases-1过表达的组织抑制剂介导三阴性乳腺癌细胞的化学抗性

IF5.2

2023-07-074

OAAI

Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells

IF5.5

2022-10-1825

OAAI

Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles

IF5.5

2022-03-1229

OAAI

Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof

IF5.5

2021-12-2428

OAAI

Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2021-07-2262

OAAI

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2020-09-0743

OAAI

Toward biomarkers discovery: Profiling triple-negative breast cancer cells by cell-SELEX

CANCER RESEARCH

IF16.6

2020-08-150

PRE

TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities

TNBC挑战: 用于新成像和治疗方式的寡核苷酸适体

PHARMACEUTICALS

IF4.8

2018-11-1340

OAAI

Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2018-04-0133

PREAI

Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer

IF13.3

2018-01-0151

OAAI

Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2017-05-10105

PREAI

Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers

适体介导的EGFR-整合素 αvβ3复合物的损伤抑制血管生成拟态和三阴性乳腺癌的生长

SCIENTIFIC REPORTS

IF3.9

2017-04-2075

OAAI

Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer

IF13.3

2017-01-0170

OAAI

PDGFRβ inhibition by Gint4.T aptamer prevents recruitment of bone marrow-derived mesenchymal stem cells into breast cancer microenvironment

EUROPEAN JOURNAL OF CANCER

IF7.1

2016-07-011

PREAI

Oligonucleotide aptamers as innovative therapeutic tools for triple-negative breast cancers

EUROPEAN JOURNAL OF CANCER

IF7.1

2016-07-010

PREAI

Aptamer-mediated inhibition of EGFRvIII mutant in glioblastoma cells

CANCER RESEARCH

IF16.6

2015-08-010

PRE